According to Casa Systems Inc’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:33 PM, company SVP of Operations, Xie Lucy disclosed selling 83,332 shares at a cost of $11.33. At the time of this transaction (Feb 19), this trade was worth $943,735 in total. […]
According to Zions Bancorporation, National Association /Ut/’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:23 PM, company EVP – Chief Risk Officer, Maio Keith D disclosed selling 2,000 shares at a cost of $51.39. At the time of this transaction (Feb 19), this trade […]
According to Zions Bancorporation, National Association /Ut/’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:19 PM, company Executive Vice President, Law Scott A. disclosed selling 1,500 shares at a cost of $51.81. At the time of this transaction (Feb 19), this trade was worth […]
According to Processa Pharmaceuticals, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:13 PM, company 10% Owner, Besser James E disclosed selling 20,929 shares at a cost of $11.56. At the time of this transaction (Feb 22), this trade was worth $241,939 in total. […]
According to Processa Pharmaceuticals, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:13 PM, company 10% Owner, Besser James E disclosed selling 3,000 shares at a cost of $11.20. At the time of this transaction (Feb 19), this trade was worth $33,600 in total. […]
According to Processa Pharmaceuticals, Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:13 PM, company 10% Owner, Besser James E disclosed selling 5,000 shares at a cost of $11.35. At the time of this transaction (Feb 18), this trade was worth $56,750 in total. […]
According to Karyopharm Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:12 PM, company EVP, Chief Medical Officer, Shah Jatin disclosed selling 1,186 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $17,590 in […]
According to Karyopharm Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:11 PM, company EVP, Chief Dev. Officer, Frenkel Ran disclosed selling 2,887 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $42,818 in […]
According to Karyopharm Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:10 PM, company President & CSO, Shacham Sharon disclosed selling 9,495 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $140,822 in total. […]
According to Karyopharm Therapeutics Inc.’s most recent Statement Of Changes In Beneficial Ownership – Form 4 filing with the SEC dated Feb 22 08:10 PM, company President & CSO, Shacham Sharon disclosed selling 9,495 shares at a cost of $14.83. At the time of this transaction (Feb 18), this trade was worth $140,822 in total. […]
PayPal Withdrawing Support For Kindle Fire, BlackBerry And Windows Phone
Revival Of Nashville Discussed
Brawl Erupts After Jose Bautista Downed By Rougned Odor Punch
VR Tour Offered Three Decades After Chernobyl Disaster
Kyle Busch Sweeps NASCAR Events At Martinsville
Halle Berry Enters The Social Media World
